Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Naoya Shigesada"'
Autor:
Maaya Morita, Aki Yoneda, Nagisa Tokunoh, Tatsumi Masaki, Keisuke Shirakura, Mayumi Kinoshita, Rina Hashimoto, Naoya Shigesada, Junya Takahashi, Masashi Tachibana, Shota Tanaka, Masanori Obana, Nobumasa Hino, Masahito Ikawa, Kazutake Tsujikawa, Chikako Ono, Yoshiharu Matsuura, Hiroyasu Kidoya, Nobuyuki Takakura, Yoshiaki Kubota, Takefumi Doi, Kazuo Takayama, Yasuo Yoshioka, Yasushi Fujio, Yoshiaki Okada
Publikováno v:
Proceedings of the National Academy of Sciences. 120
There is an urgent need to develop novel drugs to reduce the mortality from severe infectious diseases with the emergence of new pathogens, including Coronavirus disease 2019 (COVID-19). Although current drugs effectively suppress the proliferation o
Autor:
Yoshiaki Okada, Nana Yamamoto, William C. Aird, Ryosuke Ishiba, Taito Kashio, Miki Sakai, Keisuke Shirakura, Shiori Manabe, Takefumi Doi, Yu Fukushima, Naoya Shigesada, Toru Tanaka, Nobumasa Hino
Publikováno v:
Biochemical and biophysical research communications. 495(1)
Roundabout4 (Robo4) is an endothelial cell-specific receptor that stabilizes vasculature in pathological angiogenesis. Previous studies have shown that Robo4 is a potential therapeutic target for inflammatory diseases, but its precise roles in inflam
Autor:
Fumito Wada, Tsuyoshi Yamamoto, Naoya Shigesada, Hidenori Yasuhara, Satoshi Obika, Mariko Harada-Shiba, Shunsuke Wada, Naoko Fujii
Publikováno v:
Nucleic Acid Therapeutics. 24:283-290
The multiple-turnover ability of a series of locked nucleic acid (LNA)-based antisense oligonucleotides (AONs) in the RNase H-mediated scission reaction was estimated using a newly developed cell-free reaction system. We determined the initial reacti